By Super Admin

Seeking Alpha / - 34 minutes from now

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

VANCOUVER, British Columbia and BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced multiple pres...